ALNY
Alnylam Pharmaceuticals Inc
219.90$
+0.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.71 | 3.50 | 3.92 | 5.21 | 3.90 | 4.61 | 4.58 | 5.97 | 9.09 | 8.05 | 8.44 | 9.34 | 34.75 | |
| 0.64 | 0.68 | 0.52 | 0.54 | 0.67 | 0.80 | 0.55 | 1.10 | 1.44 | 1.96 | 1.53 | 2.16 | 7.05 | |
| 5.07 | 2.82 | 3.40 | 4.66 | 3.23 | 3.81 | 4.03 | 4.86 | 7.66 | 6.09 | 6.92 | 7.18 | 27.70 | |
| 1.93 | 2.17 | 2.07 | 2.32 | 2.11 | 2.33 | 2.04 | 2.50 | 2.61 | 2.73 | 2.64 | 2.99 | 10.92 | |
| 1.52 | 1.58 | 1.67 | 1.96 | 1.72 | 2.30 | 1.85 | 2.49 | 2.34 | 2.39 | 2.33 | 2.52 | 9.53 | |
| 3.44 | 3.74 | 3.74 | 4.28 | 3.83 | 4.63 | 3.89 | 4.99 | 4.98 | 5.12 | 4.97 | 5.51 | 20.47 | |
| 1.63 | -0.93 | -0.34 | 0.38 | -0.60 | -0.82 | 0.14 | -0.12 | 2.68 | 0.97 | 1.94 | 1.67 | 7.23 | |
| 0.24 | 0.25 | 0.28 | 0.26 | 0.27 | 0.30 | 0.30 | 0.31 | 0.32 | 0.95 | 0.50 | 0.59 | 2.35 | |
| 1.15 | -1.10 | -0.50 | -0.09 | -0.85 | -1.51 | -0.32 | -0.27 | 1.74 | 1.18 | 1.60 | 1.29 | 5.78 | |
| 0.02 | 0.00 | 0.02 | 0.05 | 0.02 | -0.86 | 0.12 | 0.24 | -0.09 | -0.19 | -0.11 | 0.10 | -0.29 | |
| 1.12 | -1.10 | -0.52 | -0.13 | -0.87 | -0.65 | -0.44 | -0.51 | 1.83 | 1.37 | 1.49 | 1.19 | 5.84 | |
| 1.48 | -0.74 | -0.12 | 0.29 | -0.47 | -1.10 | 0.09 | 0.15 | 2.16 | 2.23 | 2.20 | 1.77 | 8.32 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.